Ill News
-
Updated 2 hours, 1 minute ago
Novartis AG plans to ramp up its research in Alzheimer’s disease, a potential $20 billion market lacking a major contender and littered with three high-profile drug failures in the past year alone.
-
A House defense panel has agreed with the U.S. Navy’s request to buy four additional Littoral Combat Ships in the fiscal year starting Oct. 1.
-
During President Barack Obama’s May 16 news conference, reporter Jeff Mason asked as part of his question: “And, more broadly, how do you feel about comparisons by some of your critics of this week’s scandals to those that happened under the Nixon administration?” The president responded, “I’ll let you guys engage in those comparisons, and you can go ahead and read the history, I think, and draw your own conclusions.”
-
The top U.S. general said Russian deliveries of advanced anti-ship missiles and air-defense systems to Syria risk leading Bashar al-Assad’s regime to miscalculate its military power.
-
Transocean Ltd. shareholders voted in favor of one of billionaire investor Carl Icahn’s three board nominees, while rejecting his dividend plan in favor of a lower payout supported by the company.
-
David Greiner, a Buick-GMC dealer in the Mojave Desert town of Victorville, California, keeps a Securities and Exchange Commission complaint in his desk, with passages underlined in black pen and notes scribbled in the margins, ready to pick apart the case when anyone asks.
-
Modern fiscal conservatism has wrapped itself in one whopper of a false choice: That the U.S. must decide between economic growth and the welfare state.
-
Tour de France winner Bradley Wiggins quit the Giro d’Italia because of a worsening chest infection. Ryder Hesjedal, the Italian race’s defending champion, also withdrew due to illness.
-
Mental illness in children costs $247 billion annually, a figure increasing along with the number of kids hospitalized for mood disorders, substance abuse and other psychiatric disorders, according to a U.S. report.
-
Should patients undergoing broad DNA testing for a specific ailment be told of unexpected findings that signal risk of cancer or other serious diseases, even if they don’t request the information?
|
|
Most Popular on Bloomberg
|
| |
Rate this Page